Publications An Expert Consensus to Standardise Definitions, Diagnosis and Treatment Targets for Anti-fibrotic Stricture Therapies in Crohn’s Disease Citation Rieder F, Bettenworth D, Ma C, Parker CE, Williamson LA, Nelson SA, van Assche G, Di Sabatino A, Bouhnik Y, Stidham RW, Dignass A, Rogler G, Taylor SA, Stoker J, Rimola J, Baker ME, Fletcher JG, Panes J, Sandborn WJ, Feagan BG, Jairath V. An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's disease. Aliment Pharmacol Ther. 2018 Aug;48(3):347-357. doi: 10.1111/apt.14853. Epub 2018 Jun 19. PMID: 29920726; PMCID: PMC6043370. Abstract Background: Fibrotic stricture is a common complication of Crohn’s disease (CD) affecting approximately half of all patients. No specific anti-fibrotic therapies are available; however, several therapies are currently under evaluation. Drug development for the indication of stricturing CD is hampered by a lack of standardised definitions, diagnostic modalities, clinical trial eligibility criteria, endpoints and treatment targets in stricturing CD. Tags Catheterization, Colon, Complications, Crohn's Disease, Diagnosis, Dilatation, Endoscopy, Etiology, Fibrosis, Intestinal Obstruction, Intestines, Pathology, Surgery, Therapy Read More